Esophageal Cancer Clinical Trial

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Summary

This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.

View Full Description

Full Description

OUTLINE: Patients and caregivers are randomized to 1 of 2 arms.

ARM I: Participants use PACT mHealth app.

ARM II: Participants engage in standard care with no modifications.

After completion of study intervention, participants are followed up at 3 and 6 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

PATIENT: Diagnosis of poor prognosis advanced cancer defined as locally advanced or metastatic cancer (e.g., pancreaticobiliary, esophagogastric, hepatocellular carcinoma, lung, or gynecological cancer) and/or disease progression following at least first line chemotherapy.
PATIENT: Access to a mobile device; the principal investigator (PI) will ensure that those who have access to a mobile device have access to a mobile device with internet access to ensure they can complete study procedures.
PATIENT: The ability to provide informed consent.
PATIENT: Identification of and enrollment a loved one/informal caregiver.
CAREGIVER: The person (family member or friend) whom the patient indicates being an informal caregiver.
CAREGIVER: English speaking.
CAREGIVER: 18 years of age or older.
CAREGIVER: Able to provide informed consent.
PROVIDER: Current clinical practice and/or research with advanced cancer patients.
PROVIDER: A history of 3+ years working with advanced cancer patients.
PROVIDER: 18 years of age or older. Providers across disciplines (e.g., social work, oncology) will be enrolled.

Exclusion Criteria:

PATIENT: Not fluent in English.
PATIENT: Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of >= 6 to be delivered by trained study research staff during screening).
PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer).
PATIENT: Currently receiving hospice at the time of enrollment.
PATIENT: Children and young adults under age 18.

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

490

Study ID:

NCT04515810

Recruitment Status:

Recruiting

Sponsor:

Fred Hutchinson Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

Northwell Health
Manhasset New York, 11030, United States More Info
Daniel McFarland
Contact
212-434-4552
[email protected]
Daniel McFarland
Principal Investigator
Mount Sinai Hospital
New York New York, 10029, United States More Info
Sarah Miller
Contact
212-824-7783
[email protected]
Sarah Miller
Principal Investigator
NYP/Weill Cornell Medical Center
New York New York, 10065, United States More Info
Holly Prigerson
Contact
646-962-9655
[email protected]
Holly Prigerson
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Seattle Washington, 98109, United States More Info
Claudia De Los Santos, B.S.
Contact
206-667-1565
[email protected]
Megan J Shen, PhD
Contact
206-667-4172
[email protected]
Megan J Shen, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

490

Study ID:

NCT04515810

Recruitment Status:

Recruiting

Sponsor:


Fred Hutchinson Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.